Market revenue in 2023 | USD 0.1 million |
Market revenue in 2030 | USD 0.8 million |
Growth rate | 47.1% (CAGR from 2023 to 2030) |
Largest segment | C.difficle |
Fastest growing segment | Diabetes |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | C.difficle, Crohns disease, IBS, Diabetes |
Key market players worldwide | Carbios SA, Boise Cascade Co, Assembly Biosciences Inc, Wacker Chemie AG, SGS AG, Lonza Group Ltd, Arranta Bio, 4D Pharma, NIZO, Inpac Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to live biotherapeutic products and microbiome cdmo market will help companies and investors design strategic landscapes.
C.difficle was the largest segment with a revenue share of 0% in 2023. Horizon Databook has segmented the Denmark live biotherapeutic products and microbiome cdmo market based on c.difficle, crohns disease, ibs, diabetes covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark has a well-established biopharmaceutical industry driven by advancements in technology and growing demand for new products. With a growing pipeline of live biotherapeutic and microbiome products, the demand for CDMOs is increasing in Denmark due to increasing production capacity.
Moreover, the presence of developed CDMOs and increasing R&D activities are fueling market growth. The unmet medical needs and requirement for innovative LBPs to reduce infectious & chronic disease burden are anticipated to boost market growth.
For instance, in May 2023, SBT Instruments and Biose Industrie announced a collaboration for incorporating viable cell counts into Biose’s manufacturing process. This collaboration will help create an industrial standard for the enumeration of microorganisms.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark live biotherapeutic products and microbiome cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Denmark live biotherapeutic products and microbiome cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account